Starling Oncology, Inc. Warrant
STLNW
11 hedge funds and large institutions have $821K invested in Starling Oncology, Inc. Warrant in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more capital invested
Capital invested by funds: $818K → $821K (+$3.17K)
8% less funds holding
Funds holding: 12 → 11 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FL
FreeGulliver LLC
New Orleans,
Louisiana
|
-$9.24K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$2.54K |
| 3 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$32 |
| 4 |
CS
Clear Street
New York
|
-$16 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
OMC
1
Oasis Management Company
Grand Cayman,
Cayman Islands
| $356K | – | – | – |
|
|
LP
2
LMR Partners
London,
United Kingdom
| $196K | – | – | – |
|
|
DM
3
Deerfield Management
New York
| $151K | – | – | – |
|
|
DKCM
4
Davidson Kempner Capital Management
New York
| $38.4K | – | – | – |
|
|
5
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $22.5K | -$32 | -200 | -0.1% |
|
|
WAM
6
Wolverine Asset Management
Chicago,
Illinois
| $21.8K | -$2.54K | -15,727 | -8% |
|
7
Man Group
London,
United Kingdom
| $14.2K | – | – | – |
|
8
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
| $14K | – | – | – |
|
|
AGM
9
Alpine Global Management
New York
| $4K | – | – | – |
|
|
TCM
10
Tenor Capital Management
New York
| $3.01K | – | – | – |
|
|
CS
11
Clear Street
New York
| $726 | -$16 | -100 | -2% |
|
|
FL
12
FreeGulliver LLC
New Orleans,
Louisiana
| – | -$9.24K | -76,993 | Closed |
|
STLNW Hedge Fund Activity: Q4 2025 in Review
11 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q4 2025, worth a combined $821K — up 0.39% from $818K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of STLNW and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 0 added.
The largest seller was FreeGulliver LLC, exiting entirely with an estimated $9.24K sold.
- 11 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q4 2025, down from 12 in Q3 2025.
- Funds reported $821K of Starling Oncology, Inc. Warrant stock for Q4 2025, up 0.39% quarter-over-quarter.
- 0 funds opened new Starling Oncology, Inc. Warrant positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest Starling Oncology, Inc. Warrant seller in Q4 2025 was FreeGulliver LLC, an estimated $9.24K sold.
Based on aggregated 13F filings for Q4 2025.